Product

Sublingual Dexmedetomidine

1 clinical trial

1 indication

Indication
Delirium
Clinical trial
Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Status: Not yet recruiting, Estimated PCD: 2027-10-31